TD Asset Management »

Corcept Therapeutics Incorporated shares owned by TD Asset Management

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by TD Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $80M 956k 83.11
2025-06-30 $60M 820k 73.40
2022-09-30 $25M 994k 25.54
2022-06-30 $23M 960k 23.78
2022-03-31 $22M 960k 22.52
2021-12-31 $23M 1.2M 19.80
2021-09-30 $18M 908k 19.68
2021-06-30 $19M 908k 20.77
2021-03-31 $4.0M 170k 23.79

More positions owned by TD Asset Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Rbc Cad (RY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Meta Platforms Cl A (META)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
Enbridge (ENB)
Cibc Cad (CM)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Brookfield Corp Cl A Ltd Vt Sh (BN)
JPMorgan Chase & Co. (JPM)
Agnico (AEM)

View all positions for TD Asset Management

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
AQR Capital Management
ClearBridge Advisors
Charles Schwab Investment Management
TD Asset Management
Jpmorgan Chase & Co

View all funds holding Corcept Therapeutics Incorporated